• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依普利酮预防盐诱导的 Zucker 糖尿病肥胖大鼠血管僵硬:初步报告。

Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report.

机构信息

Department of Internal Medicine II, Regensburg University Medical Center, Germany.

出版信息

Cardiovasc Diabetol. 2011 Oct 18;10:94. doi: 10.1186/1475-2840-10-94.

DOI:10.1186/1475-2840-10-94
PMID:22008236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3217853/
Abstract

BACKGROUND

Aldosterone levels are elevated in a rat model of type 2 diabetes mellitus, the Zucker Diabetic fatty rat (ZDF). Moreover blood pressure in ZDF rats is salt-sensitive. The aim of this study was to examine the effect of the aldosterone antagonist eplerenone on structural and mechanical properties of resistance arteries of ZDF-rats on normal and high-salt diet.

METHODS

After the development of diabetes, ZDF animals were fed either a normal salt diet (0.28%) or a high-salt diet (5.5%) starting at an age of 15 weeks. ZDF rats on high-salt diet were randomly assigned to eplerenone (100 mg/kg per day, in food) (ZDF+S+E), hydralazine (25 mg/kg per day) (ZDF+S+H), or no treatment (ZDF+S). Rats on normal salt-diet were assigned to eplerenone (ZDF+E) or no treatment (ZDF). Normoglycemic Zucker lean rats were also divided into two groups receiving normal (ZL) or high-salt diet (ZL+S) serving as controls. Systolic blood pressure was measured by tail cuff method. The experiment was terminated at an age of 25 weeks. Mesenteric resistance arteries were studied on a pressurized myograph. Specifically, vascular hypertrophy (media-to-lumen ratio) and vascular stiffness (strain and stress) were analyzed. After pressurized fixation histological analysis of collagen and elastin content was performed.

RESULTS

Blood pressure was significantly higher in salt-loaded ZDF compared to ZDF. Eplerenone and hydralazine prevented this rise similarily, however, significance niveau was missed. Media-to-lumen ratio of mesenteric resistance arteries was significantly increased in ZDF+S when compared to ZDF and ZL. Both, eplerenone and hydralazine prevented salt-induced vascular hypertrophy. The strain curve of arteries of salt-loaded ZDF rats was significantly lower when compared to ZL and when compared to ZDF+S+E, but was not different compared to ZDF+S+H. Eplerenone, but not hydralazine shifted the strain-stress curve to the right indicating a vascular wall composition with less resistant components. This indicates increased vascular stiffness in salt-loaded ZDF rats, which could be prevented by eplerenone but not by hydralazine. Collagen content was increased in ZL and ZDF rats on high-salt diet. Eplerenone and hydralazine prevented the increase of collagen content. There was no difference in elastin content.

CONCLUSION

Eplerenone and hydralazine prevented increased media-to-lumen ratio in salt-loaded ZDF-rats, indicating a regression of vascular hypertrophy, which is likely mediated by the blood pressure lowering-effect. Eplerenone has additionally the potential to prevent increased vascular stiffness in salt-loaded ZDF-rats. This suggests an effect of the specific aldosterone antagonist on adverse vascular wall remodelling.

摘要

背景

在 2 型糖尿病模型大鼠(Zucker 糖尿病肥胖大鼠,ZDF)中,醛固酮水平升高。此外,ZDF 大鼠的血压对盐敏感。本研究的目的是研究醛固酮拮抗剂依普利酮对 ZDF 大鼠正常和高盐饮食下阻力血管的结构和力学特性的影响。

方法

在糖尿病发展后,15 周龄时,ZDF 动物开始分别接受正常盐饮食(0.28%)或高盐饮食(5.5%)。高盐饮食的 ZDF 大鼠随机分为依普利酮(100mg/kg/天,食物中)(ZDF+S+E)、肼屈嗪(25mg/kg/天)(ZDF+S+H)或无治疗(ZDF+S)组。接受正常盐饮食的 ZDF 大鼠分为依普利酮组(ZDF+E)或无治疗组(ZDF)。正常血糖的 Zucker 瘦大鼠也分为接受正常(ZL)或高盐饮食(ZL+S)的两组,作为对照组。通过尾套法测量收缩压。实验在 25 周龄时结束。在加压肌动描记器上研究肠系膜阻力血管。具体来说,分析血管肥大(中膜与腔比)和血管僵硬(应变和应力)。加压固定后,进行胶原和弹性蛋白含量的组织学分析。

结果

与 ZDF 相比,盐负荷的 ZDF 血压明显升高。依普利酮和肼屈嗪的降压作用相似,但未达到统计学意义。与 ZDF 和 ZL 相比,ZDF+S 中的肠系膜阻力血管的中膜与腔比显著增加。依普利酮和肼屈嗪均可预防盐诱导的血管肥大。与 ZL 和 ZDF+S+E 相比,盐负荷的 ZDF 大鼠的应变曲线明显降低,但与 ZDF+S+H 相比无差异。依普利酮而非肼屈嗪使应变-应力曲线向右移动,表明血管壁组成中阻力成分减少。这表明盐负荷的 ZDF 大鼠的血管僵硬增加,依普利酮可预防,但肼屈嗪不能预防。ZL 和高盐饮食的 ZDF 大鼠的胶原含量增加。依普利酮和肼屈嗪可预防胶原含量的增加。弹性蛋白含量无差异。

结论

依普利酮和肼屈嗪可预防盐负荷的 ZDF 大鼠中膜与腔比的增加,表明血管肥大的消退,这可能是通过降压作用介导的。依普利酮还有预防盐负荷的 ZDF 大鼠血管僵硬增加的潜力。这表明特定的醛固酮拮抗剂对不良血管壁重塑有作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7295/3217853/035abf581552/1475-2840-10-94-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7295/3217853/2ce9def04d59/1475-2840-10-94-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7295/3217853/f772ce930306/1475-2840-10-94-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7295/3217853/3d751bc85202/1475-2840-10-94-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7295/3217853/19d79cb6be8d/1475-2840-10-94-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7295/3217853/035abf581552/1475-2840-10-94-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7295/3217853/2ce9def04d59/1475-2840-10-94-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7295/3217853/f772ce930306/1475-2840-10-94-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7295/3217853/3d751bc85202/1475-2840-10-94-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7295/3217853/19d79cb6be8d/1475-2840-10-94-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7295/3217853/035abf581552/1475-2840-10-94-5.jpg

相似文献

1
Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report.依普利酮预防盐诱导的 Zucker 糖尿病肥胖大鼠血管僵硬:初步报告。
Cardiovasc Diabetol. 2011 Oct 18;10:94. doi: 10.1186/1475-2840-10-94.
2
Hyperaldosteronism and altered expression of an SGK1-dependent sodium transporter in ZDF rats leads to salt dependence of blood pressure.原发性醛固酮增多症和 SGK1 依赖性钠转运体表达改变导致 ZDF 大鼠血压的盐依赖性。
Hypertens Res. 2010 Oct;33(10):1082-8. doi: 10.1038/hr.2010.132. Epub 2010 Jul 22.
3
Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.依普利酮可预防盐诱导的易中风自发性高血压大鼠的血管重塑和心脏纤维化。
Hypertension. 2004 Jun;43(6):1252-7. doi: 10.1161/01.HYP.0000128031.31572.a3. Epub 2004 Apr 26.
4
Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism.血管紧张素 II 输注大鼠的阻力动脉力学与组成:醛固酮拮抗作用的影响
J Hypertens. 2003 Jan;21(1):189-98. doi: 10.1097/00004872-200301000-00029.
5
Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone.醛固酮-盐处理大鼠颈动脉壁弹性模量和纤连蛋白增加:依普利酮的作用
Circulation. 2002 Nov 26;106(22):2848-53. doi: 10.1161/01.cir.0000039328.33137.6c.
6
Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes.依普利酮可减轻实验性 2 型糖尿病心脏脂肪变性、细胞凋亡和舒张功能障碍。
Cardiovasc Diabetol. 2013 Nov 21;12:172. doi: 10.1186/1475-2840-12-172.
7
Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat.罗格列酮可预防Zucker糖尿病脂肪大鼠高血糖症和蛋白尿的发生。
Diabetes Obes Metab. 2000 Dec;2(6):363-72. doi: 10.1046/j.1463-1326.2000.00099.x.
8
Aldosterone Synthase Inhibition Improves Glucose Tolerance in Zucker Diabetic Fatty (ZDF) Rats.醛固酮合酶抑制改善Zucker糖尿病脂肪大鼠(ZDF大鼠)的葡萄糖耐量。
Endocrinology. 2016 Oct;157(10):3844-3855. doi: 10.1210/en.2016-1358. Epub 2016 Aug 15.
9
Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats.抗糖尿病治疗可恢复脂联素血清水平和 APPL1 表达,但不能改善 Zucker 糖尿病肥胖大鼠脂联素诱导的血管舒张和内皮功能障碍。
Cardiovasc Diabetol. 2013 Mar 18;12:46. doi: 10.1186/1475-2840-12-46.
10
Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.依那普利、替莫泊尔和依普利酮对盐敏感性 Dahl 大鼠盐诱导高血压的影响。
Clin Exp Hypertens. 2006 Feb;28(2):121-32. doi: 10.1080/10641960500468276.

引用本文的文献

1
The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function.成纤维细胞生长因子 23 对血管平滑肌细胞表型和功能的直接影响。
Nephrol Dial Transplant. 2023 Feb 13;38(2):322-343. doi: 10.1093/ndt/gfac220.
2
Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling.螺内酯治疗通过降低氧化应激和恢复一氧化氮/鸟苷酸环化酶信号传导来减轻2型糖尿病小鼠的血管功能障碍。
Front Physiol. 2015 Oct 5;6:269. doi: 10.3389/fphys.2015.00269. eCollection 2015.
3
Oxidative stress causes imbalance of renal renin angiotensin system (RAS) components and hypertension in obese Zucker rats.

本文引用的文献

1
Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in zucker diabetic fatty rats.在 Zucker 糖尿病肥胖大鼠中,糖异生缺陷导致其无法在高血糖和高胰岛素血症时抑制肝葡萄糖生成。
Diabetes. 2011 Sep;60(9):2225-33. doi: 10.2337/db09-1156. Epub 2011 Jul 19.
2
Sex-dependent hepatic transcripts and metabolites in the development of glucose intolerance and insulin resistance in Zucker diabetic fatty rats.在 Zucker 糖尿病肥胖大鼠葡萄糖耐量和胰岛素抵抗的发展过程中,性别依赖性肝转录物和代谢物。
J Mol Endocrinol. 2011 Aug 25;47(2):129-43. doi: 10.1530/JME-11-0007. Print 2011 Oct.
3
氧化应激导致肥胖 Zucker 大鼠肾素血管紧张素系统(RAS)各组分失衡及高血压。
J Am Heart Assoc. 2015 Feb 16;4(2):e001559. doi: 10.1161/JAHA.114.001559.
4
Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness.平滑肌细胞盐皮质激素受体对于醛固酮-盐诱导的血管僵硬是必需的。
Hypertension. 2014 Mar;63(3):520-526. doi: 10.1161/HYPERTENSIONAHA.113.01967. Epub 2013 Dec 2.
5
Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes.依普利酮可减轻实验性 2 型糖尿病心脏脂肪变性、细胞凋亡和舒张功能障碍。
Cardiovasc Diabetol. 2013 Nov 21;12:172. doi: 10.1186/1475-2840-12-172.
6
The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness.组织肾素-血管紧张素-醛固酮系统在内皮功能障碍和动脉僵硬度发展中的作用。
Front Endocrinol (Lausanne). 2013 Oct 29;4:161. doi: 10.3389/fendo.2013.00161.
7
Rationale and design of a randomized trial on the impact of aldosterone antagonism on cardiac structure and function in diabetic cardiomyopathy.在糖尿病心肌病中,醛固酮拮抗作用对心脏结构和功能影响的随机临床试验的原理和设计。
Cardiovasc Diabetol. 2013 Oct 1;12:139. doi: 10.1186/1475-2840-12-139.
8
The role of fibrosis in Duchenne muscular dystrophy.纤维化在杜氏肌营养不良症中的作用。
Acta Myol. 2012 Dec;31(3):184-95.
9
Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes.维生素 D 对链脲佐菌素诱导糖尿病主动脉重塑的影响。
Cardiovasc Diabetol. 2012 Jul 13;11:58. doi: 10.1186/1475-2840-11-58.
Globular and full-length adiponectin induce NO-dependent vasodilation in resistance arteries of Zucker lean but not Zucker diabetic fatty rats.
球形和全长脂联素诱导 Zucker lean 但不诱导 Zucker 糖尿病肥胖大鼠阻力血管的 NO 依赖型舒张。
Am J Hypertens. 2011 Mar;24(3):270-7. doi: 10.1038/ajh.2010.239. Epub 2010 Dec 9.
4
Hyperaldosteronism and altered expression of an SGK1-dependent sodium transporter in ZDF rats leads to salt dependence of blood pressure.原发性醛固酮增多症和 SGK1 依赖性钠转运体表达改变导致 ZDF 大鼠血压的盐依赖性。
Hypertens Res. 2010 Oct;33(10):1082-8. doi: 10.1038/hr.2010.132. Epub 2010 Jul 22.
5
Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle.Zucker 糖尿病肥胖大鼠的糖尿病心肌病:被遗忘的右心室。
Cardiovasc Diabetol. 2010 Jun 15;9:25. doi: 10.1186/1475-2840-9-25.
6
Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats.罗格列酮可逆转糖尿病脂联素缺乏肥胖大鼠股动脉内皮功能障碍,但不能逆转其重构。
Cardiovasc Diabetol. 2010 May 19;9:19. doi: 10.1186/1475-2840-9-19.
7
Alterations in mechanical properties of mesenteric resistance arteries in experimental portal hypertension.实验性门静脉高压症肠系膜阻力血管力学特性的改变。
Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G849-57. doi: 10.1152/ajpgi.00084.2009. Epub 2009 Aug 20.
8
Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.选择性盐皮质激素受体阻滞剂依普利酮可降低高血压患者的阻力动脉僵硬度。
Hypertension. 2008 Feb;51(2):432-9. doi: 10.1161/HYPERTENSIONAHA.107.103267. Epub 2008 Jan 14.
9
Sodium, arterial stiffness, and cardiovascular mortality in hypertensive rats.高血压大鼠中的钠、动脉僵硬度与心血管死亡率
Am J Hypertens. 2007 Mar;20(3):319-25. doi: 10.1016/j.amjhyper.2006.09.002.
10
Differences between cardiac and arterial fibrosis and stiffness in aldosterone-salt rats: effect of eplerenone.醛固酮-盐大鼠中心脏与动脉纤维化及僵硬度的差异:依普利酮的作用
J Renin Angiotensin Aldosterone Syst. 2006 Mar;7(1):31-9. doi: 10.3317/jraas.2006.004.